Abstract
The incidence and prevalence of chronic heart failure (CHF) increase with age. In the second edition of the National Disease Management Guidelines (NVL) on CHF, published in August 2017, geriatric aspects are specifically addressed. The paper provides an overview of the recommendations by the guidelines on drug therapy, device therapy and operative therapy as well on the coordination of care focusing on older and multimorbid patients.
Keywords:
Guideline; Heart failure; Multimorbidity; Older patients; Polypharmacy.
MeSH terms
-
Adrenergic beta-Antagonists / therapeutic use
-
Aged
-
Angiotensin II Type 1 Receptor Blockers / therapeutic use
-
Angiotensin-Converting Enzyme Inhibitors / therapeutic use
-
Cardiac Resynchronization Therapy
-
Chronic Disease
-
Comorbidity
-
Coronary Artery Bypass
-
Cross-Sectional Studies
-
Defibrillators, Implantable
-
Delivery of Health Care*
-
Diuretics / therapeutic use
-
Drug Therapy, Combination
-
Geriatrics
-
Germany
-
Guideline Adherence*
-
Heart Failure / epidemiology
-
Heart Failure / therapy*
-
Humans
-
Interdisciplinary Communication
-
Intersectoral Collaboration
Substances
-
Adrenergic beta-Antagonists
-
Angiotensin II Type 1 Receptor Blockers
-
Angiotensin-Converting Enzyme Inhibitors
-
Diuretics